Additional Affiliate Investigators

Research Management Partners Network

In addition to the Principal Investigators and Sub-Investigators featured in our main investigator pages, Research Management Partners collaborates with a broader network of physicians and clinical professionals who support research activities across affiliated clinical sites.

These affiliate investigators contribute valuable clinical expertise across multiple specialties and participate in clinical research programs as Principal Investigators, Sub-Investigators, or collaborating physicians depending on study requirements and site participation.

Our extended network strengthens RMP’s ability to support diverse therapeutic areas while expanding patient access and investigator availability across Florida and Puerto Rico.

Ariel J. Mir Remedios, MD
Principal Investigator | Internal Medicine

Dr. Ariel J. Mir Remedios is a licensed physician with extensive clinical experience in internal medicine, family medicine, and surgical care. He obtained his medical degree from the Higher Institute of Medical Sciences in Santiago de Cuba and later completed advanced medical training and board certification in Family Medicine in Spain. Throughout his career, he has worked in multiple international healthcare systems including Cuba, Spain, Puerto Rico, and the United States, bringing a broad clinical perspective to patient care and research environments.

As a Sub-Investigator in clinical research, Dr. Mir has participated in numerous Phase II–IV industry-sponsored clinical trials across diverse therapeutic areas including pulmonology, gastroenterology, cardiology, neurology, rheumatology, and infectious diseases. His research experience includes studies in idiopathic pulmonary fibrosis, Crohn’s disease, heart failure, migraine treatment, COPD, asthma therapies, cardiovascular safety trials, osteoarthritis treatments, and COVID-19 therapies.

Dr. Mir is trained in Good Clinical Practice (ICH-GCP), FDA regulatory requirements, adverse event reporting, informed consent procedures, and investigator responsibilities. His experience in multicenter randomized clinical trials and his multidisciplinary medical background contribute to strong protocol compliance, patient safety oversight, and high-quality data collection within the Research Management Partners clinical research network.

Olga L. Mendoza, MD
Principal Investigator | Family Medicine & Clinical Research

Dr. Olga L. Mendoza is an experienced physician and medical director with more than three decades of clinical and leadership experience across family medicine, emergency medicine, preventive care, and community-based healthcare services. Throughout her career she has held multiple leadership roles as Medical Director and physician across healthcare organizations in Florida and Puerto Rico, providing comprehensive patient care and overseeing multidisciplinary medical teams.

As a Principal Investigator and Sub-Investigator, Dr. Mendoza has participated in numerous Phase II–IV industry-sponsored clinical trials across a wide range of therapeutic areas including respiratory diseases, infectious diseases, metabolic disorders, cardiovascular conditions, mental health, and pharmacogenomics. Her research portfolio includes studies in COPD, chronic kidney disease–related anemia, diabetes mellitus, COVID-19 therapies, vaccine development, depression, schizophrenia, narcolepsy, Sjögren’s syndrome, hypercholesterolemia, and Alzheimer’s disease.

Dr. Mendoza is extensively trained in regulatory and operational aspects of clinical research including Good Clinical Practice (ICH-GCP), FDA-regulated studies, informed consent procedures, adverse event reporting, electronic data capture systems, and sponsor monitoring processes. Her experience leading research teams and managing complex study operations contributes to high-quality protocol execution, patient safety oversight, and reliable data integrity across the Research Management Partners clinical research network.

Armand J. Bermudez, MD
Principal Investigator / Sub-Investigator | Pulmonology & Internal Medicine

Dr. Armand J. Bermudez is a senior pulmonologist and internal medicine physician with extensive clinical experience in pulmonary medicine, critical care, and hospital-based patient management. Over the course of his career he has held leadership roles in both academic and hospital environments, including clinical faculty appointments and medical staff leadership positions. His clinical expertise includes the diagnosis and management of respiratory diseases such as asthma, pulmonary fibrosis, sarcoidosis, interstitial lung disease, pneumonia, and other complex pulmonary conditions.

In clinical research, Dr. Bermudez serves as a Principal Investigator and Sub-Investigator in Phase II–III industry-sponsored clinical trials focusing on respiratory and infectious diseases. His research portfolio includes studies in chronic obstructive pulmonary disease (COPD), COVID-19 prevention and diagnostics, and cardiovascular and tobacco exposure studies. He has extensive experience conducting protocol-driven pulmonary evaluations, patient eligibility assessments, safety monitoring, and informed consent procedures in multicenter clinical trials.

Dr. Bermudez completed advanced fellowship training in Pulmonary and Critical Care Medicine and has participated in numerous regulatory-compliant research programs in collaboration with sponsors, CROs, and site management organizations. His training in ICH-GCP standards, regulatory oversight, and clinical trial documentation supports high-quality protocol compliance, patient safety oversight, and reliable clinical data collection across the Research Management Partners clinical research network.

Jorge Ernesto Sandelis Perez, MD
Internal Medicine | Principal Investigator

Dr. Jorge Ernesto Sandelis Perez is a board-certified Internal Medicine physician based in Miami, Florida, with an established clinical practice serving a diverse adult patient population.

Dr. Sandelis provides comprehensive care for a wide range of chronic and acute conditions, including cardiometabolic disorders such as diabetes, hypertension, and obesity. His clinical setting allows direct access to a consistent patient base, supporting efficient identification and recruitment of eligible participants for clinical trials.

Through his affiliation with Research Management Partners (RMP), Dr. Sandelis is supported by a structured clinical research infrastructure, including centralized SOPs, regulatory oversight, and patient pre-screening through EMR systems. This enables high-quality study execution while maintaining continuity of patient care.

Fluent in both English and Spanish, Dr. Sandelis is well-positioned to engage diverse patient populations and contribute to successful enrollment and retention across multiple therapeutic areas.

Tomas Iglesias, MD
Principal Investigator | Cardiology & Rheumatology

Dr. Tomas Iglesias is a senior physician with more than five decades of clinical and academic experience in internal medicine, cardiology, and rheumatology. Throughout his career he has combined private medical practice, clinical leadership, and research participation across multiple international healthcare systems including Cuba, Spain, and the United States. His medical training includes advanced fellowship-level experience in arthritis and extensive clinical work in cardiovascular and rheumatologic care.

In clinical research, Dr. Iglesias has served as a Principal Investigator and Sub-Investigator in numerous Phase II–IV multicenter clinical trials across multiple therapeutic areas including cardiology, pulmonology, gastroenterology, neurology, infectious diseases, vaccines, and medical devices. His research portfolio includes studies involving idiopathic pulmonary fibrosis, Crohn’s disease, heart failure, asthma, chronic obstructive pulmonary disease (COPD), osteoarthritis, migraine, and cardiovascular safety studies in patients with rheumatologic conditions.

Dr. Iglesias is extensively trained in regulatory compliance for clinical research, including Good Clinical Practice (ICH-GCP), adverse event reporting, informed consent procedures, sponsor monitoring processes, and electronic data capture systems. His experience supervising clinical trial protocols and ensuring participant safety contributes to strong protocol adherence, data integrity, and reliable study execution across the Research Management Partners clinical research network.

Guido A. Perez, MD
Principal Investigator | Internal Medicine & Clinical Research

Dr. Guido A. Perez is a board-certified physician licensed in the State of Florida with extensive experience in internal medicine, community-based patient care, and clinical research leadership. With decades of medical practice and experience managing diverse patient populations, he integrates clinical medicine with research operations within established healthcare settings. His clinical background includes the management of chronic diseases, metabolic disorders, cardiovascular conditions, and complex adult medical conditions.

As a Principal Investigator, Dr. Perez has participated in a large portfolio of Phase I–IV multicenter clinical trials across numerous therapeutic areas. His research experience includes studies in asthma, COPD, Alzheimer’s disease, major depressive disorder, generalized anxiety disorder, rheumatoid arthritis, psoriasis, diabetes, hyperlipidemia, cardiovascular disease, osteoporosis, migraine, infectious diseases, and HIV. He has extensive experience conducting randomized, double-blind, placebo-controlled trials as well as long-term safety extension studies and dose-ranging investigations.

Dr. Perez maintains direct oversight of clinical trial operations including protocol implementation, participant safety monitoring, regulatory compliance, and communication with sponsors and CROs. His training in Good Clinical Practice (GCP), combined with years of investigator leadership, supports reliable study execution, regulatory compliance, and high-quality clinical data generation across the Research Management Partners clinical research network.

Giralt Yanez Ramos, MD
Internal Medicine | Principal Investigator

Dr. Giralt Yanez Ramos is an Internal Medicine physician based in Miami, Florida, with over a decade of clinical practice experience. He provides comprehensive care to a diverse adult patient population, managing a wide range of acute and chronic medical conditions.

Dr. Ramos’s clinical practice supports the management of cardiometabolic disorders, including diabetes, hypertension, and obesity, offering access to a consistent and relevant patient population for clinical research.

Through his affiliation with Research Management Partners (RMP), Dr. Ramos is supported by a structured research infrastructure, including centralized SOPs, regulatory oversight, and EMR-based patient pre-screening. This model enables efficient patient identification, enrollment, and high-quality study execution.

Fluent in English and Spanish, Dr. Ramos contributes to effective patient engagement and retention across diverse communities, supporting successful clinical trial outcomes.

Ariel Goitia, MD
Principal Investigator / Sub-Investigator | Psychiatry

Dr. Ariel Goitia is a board-certified psychiatrist with extensive clinical and research experience across adult, adolescent, and geriatric psychiatry. He has worked in multiple clinical environments including inpatient psychiatry, emergency psychiatric care, outpatient clinics, and telepsychiatry services. Dr. Goitia currently practices as an attending psychiatrist and brings strong expertise in psychiatric evaluation, medication management, and multidisciplinary mental health treatment across diverse patient populations.

In clinical research, Dr. Goitia serves as a Principal Investigator and Sub-Investigator in Phase II–III industry-sponsored interventional psychiatry trials. His research work includes studies involving major depressive disorder, bipolar depression, psychosis associated with Alzheimer’s disease, agitation in dementia, and neuropsychiatric complications related to COVID-19. He is experienced in patient recruitment, eligibility assessments, safety oversight, informed consent procedures, and maintaining strict protocol compliance in multicenter clinical trials.

Dr. Goitia is also a highly experienced clinical rater trained in administering standardized psychiatric assessment tools used in CNS clinical trials, including MADRS, PANSS, HAM-D, HAM-A, CGI scales, C-SSRS, MMSE, SCID, and ADAS-Cog. His strong background in clinical psychiatry, regulatory-compliant research practices, and collaboration with sponsors and CROs supports high-quality data integrity and patient safety across the Research Management Partners clinical research network.

Alberto Orta, MD

Principal Investigator

Dr. Alberto Orta is a board-certified physician with over a decade of multidisciplinary clinical experience and a strong background in clinical research. He currently serves as a Principal Investigator within Research Management Partners (RMP), actively leading Phase II–III clinical trials across multiple therapeutic areas.

Dr. Orta has extensive experience in FDA-regulated research, including protocol execution, subject safety oversight, SAE reporting, IRB coordination, and data management using EDC systems. He has participated in a wide range of studies spanning respiratory diseases (asthma, COPD), dermatology (atopic dermatitis, psoriasis), neurology (Alzheimer’s disease), cardiovascular conditions (hypertension), gastroenterology (NASH), urology (BPH), and oncology screening programs.

His clinical and research expertise is complemented by formal training in ICH-GCP, regulatory compliance, and investigational product management. In addition, Dr. Orta is certified as a clinical rater for psychiatric and neurological assessments, further strengthening his ability to support CNS-related studies.

With a strong commitment to data quality, protocol adherence, and patient-centered care, Dr. Orta contributes to consistent study execution, reliable enrollment, and high retention across clinical trials.

Ruben Cabrera, MD

Principal Investigator | Board-Certified Internal Medicine, Pulmonary & Critical Care

Dr. Ruben Cabrera is a triple board-certified physician in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine, with extensive experience as a Principal Investigator and Sub-Investigator in Phase II–IV clinical trials.

He brings strong expertise in respiratory and cardiometabolic research, with a focus on conditions such as asthma, COPD, interstitial lung disease, pulmonary hypertension, and obesity-related comorbidities. His clinical background in critical care enhances his ability to manage complex patient populations and ensure high standards of safety and protocol adherence.

Dr. Cabrera has collaborated with leading pharmaceutical sponsors and CROs including AbbVie, Pfizer, Novartis, Janssen, IQVIA, PPD, and Syneos Health, contributing to the successful execution of multiple high-level clinical trials. His research portfolio includes studies in dermatology (psoriasis, atopic dermatitis), psychiatry (PTSD, schizophrenia), addiction medicine, rheumatology, and infectious diseases, demonstrating broad therapeutic versatility.

He has led and supported numerous Phase II–III studies in respiratory and systemic diseases, including COPD exacerbations, severe asthma, pulmonary fibrosis, and cardiopulmonary conditions, consistently supporting enrollment, patient safety, and data integrity.

Dr. Cabrera is certified in Good Clinical Practice (GCP) and maintains strong compliance with FDA and ICH-GCP standards, ensuring audit readiness and high-quality study execution across all assigned trials.

Michel Balan, APRN, fMD.
Sub-Investigator | Family Medicine & Clinical Research

Michel Balan is a physician and Advanced Practice Registered Nurse with extensive experience in family medicine and clinical research operations. He currently serves as Sub-Investigator and Site Director, supporting the execution of FDA-regulated clinical trials across multiple therapeutic areas. His professional background combines medical training as a physician with advanced nursing practice, providing comprehensive clinical expertise in patient evaluation, safety monitoring, and multidisciplinary care.

In clinical research, Mr. Balan has participated in numerous Phase I–IV industry-sponsored clinical trials covering a broad range of therapeutic areas including respiratory diseases, infectious diseases, metabolic disorders, psychiatry, neurology, cardiovascular conditions, and vaccine development. His research portfolio includes studies involving COPD, chronic kidney disease–related anemia, diabetes mellitus, influenza prevention, COVID-19 antiviral therapies, schizophrenia, narcolepsy, major depressive disorder, Alzheimer’s disease, hypercholesterolemia, dermatologic conditions, and oncology screening programs.

Mr. Balan is trained in Good Clinical Practice (ICH-GCP), FDA regulatory requirements, AE/SAE reporting, electronic data capture systems, and sponsor monitoring processes. He is also an experienced clinical rater certified in psychiatric assessment scales including MADRS, CGI, C-SSRS, SCID, and QIDS-SR-16. His combined clinical and operational research experience supports strong protocol compliance, patient safety oversight, and high-quality data integrity across the Research Management Partners clinical research network.

Ivelis Cervantes, MSN, APRN, FNP-C, MD
Sub-Investigator | Family Medicine & Clinical Research

Ivelis Cervantes is a board-certified Family Nurse Practitioner and internationally trained physician with extensive experience across primary care, nursing practice, and clinical research operations. Her professional background combines medical training as a physician with advanced nursing education in the United States, providing a comprehensive clinical foundation for patient care across adult, pediatric, and geriatric populations. She currently practices as an APRN in primary care settings while supporting research activities within the Research Management Partners clinical network.

In clinical research, Ms. Cervantes has participated in Phase II and Phase III industry-sponsored clinical trials and has extensive experience as a Clinical Research Coordinator managing day-to-day study operations. Her responsibilities have included patient screening and eligibility verification, informed consent procedures, collection of medical histories and vital signs, investigational product handling, source documentation, and completion of electronic case report forms (eCRFs) in accordance with ALCOA+ data integrity principles.

Ms. Cervantes is trained in Good Clinical Practice (ICH-GCP), Human Subjects Protection, HIPAA compliance, and regulatory requirements for FDA-regulated research studies. Her combined clinical and research experience supports protocol implementation, patient safety oversight, monitoring readiness, and collaboration with investigators, sponsors, and CROs to ensure reliable study execution and high-quality clinical data across the Research Management Partners clinical research network.

Harold Iparraguirre, APRN, FNP
Sub-Investigator | Internal Medicine & Clinical Research

Harold Iparraguirre is an Advanced Practice Registered Nurse and internationally trained physician with extensive experience in internal medicine, family medicine, and clinical research operations. His medical training includes a Doctor of General Medicine degree and internal medicine specialization obtained internationally, followed by advanced nursing education in the United States. His clinical background spans general medicine, chronic disease management, infectious diseases, respiratory medicine, hepatology, and metabolic disorders, providing a broad foundation for patient care within research environments.

As a Sub-Investigator and former Clinical Research Coordinator, Mr. Iparraguirre brings more than a decade of experience in industry-sponsored clinical trials. He has participated in multiple Phase II and Phase III studies across therapeutic areas including COVID-19 antiviral therapies, chronic hepatitis B treatment, diabetic foot infections, respiratory disease management, dermatology conditions, gastrointestinal disorders, and cardiovascular outcomes in patients with type 2 diabetes. His experience includes working with sponsors such as Shionogi, Gilead, GSK, VIR Biotechnology, and other global pharmaceutical research programs.

Mr. Iparraguirre is trained in Good Clinical Practice (ICH-GCP), NIH clinical research standards, and regulatory compliance for FDA-regulated studies. His responsibilities include subject eligibility evaluations, informed consent procedures, protocol implementation, adverse event documentation, and electronic data capture system utilization. His bilingual communication skills and multidisciplinary research experience support high-quality study execution and patient safety within the Research Management Partners clinical research network.

Maria Antonia Monzon, APRN-C, MSN

Sub-Investigator | Family Nurse Practitioner

Maria Antonia Monzon is an experienced Family Nurse Practitioner and Sub-Investigator with a strong clinical and research background supporting Phase II–III clinical trials across multiple therapeutic areas.

With over a decade of experience in patient care and clinical research operations, she plays a key role in study execution, patient management, and protocol adherence. Her research experience includes studies in respiratory diseases (asthma, COPD), dermatology (psoriasis, atopic dermatitis, acne), metabolic conditions (NASH), infectious diseases (COVID-19), oncology screening, and musculoskeletal disorders.

Ms. Monzon is extensively trained in ICH-GCP, FDA-regulated research, adverse event reporting, informed consent processes, and investigational product management. She is also a certified clinical rater for multiple psychiatric and neurological scales, including C-SSRS, CGI, MADRS, and SCID-based assessments, supporting high-quality data collection in CNS studies.

Her multidisciplinary background as a physician (internationally trained), nurse, and advanced practice provider enhances her ability to engage diverse patient populations and support high retention rates. Bilingual in English and Spanish, she contributes significantly to patient recruitment and community engagement.

Maria Antonia Monzon is a key operational asset in clinical trials, ensuring efficient study execution, patient compliance, and data quality across all assigned protocols.

Lisandra Martínez Salazar, MSN, APRN, PMHNP-BC
Sub-Investigator | Psychiatry

Lisandra Martínez Salazar is a board-certified Psychiatric Mental Health Nurse Practitioner with extensive clinical and research experience in behavioral health. She provides comprehensive psychiatric evaluations, DSM-5 diagnostic assessments, medication management, and evidence-based treatment planning across diverse adult patient populations. Her background includes outpatient psychiatric care, clinical leadership, and multidisciplinary collaboration within community mental health and healthcare settings.

In clinical research, Ms. Martínez Salazar serves as a Sub-Investigator and trained clinical rater in Phase II–III industry-sponsored psychiatry clinical trials. She performs protocol-driven psychiatric assessments, administers standardized clinician-rated and patient-reported outcome scales, conducts informed consent procedures, and supports patient safety monitoring including adverse event identification and documentation. Her experience includes studies evaluating treatments for depression, anxiety disorders, ADHD, insomnia, mood disorders, and tardive dyskinesia.

Ms. Martínez Salazar is trained in Good Clinical Practice (ICH-GCP), Human Subjects Protection, and regulatory-compliant clinical research procedures. She maintains strict adherence to sponsor protocols, ALCOA+ documentation standards, and quality oversight processes while collaborating with investigators, sponsors, and CRO teams. Her expertise in psychiatric rating scales and protocol execution contributes to reliable study performance and data integrity across the Research Management Partners clinical research network.

Liliana Alonso Yanez, MSN, APRN, PMHNP-BC
Sub-Investigator | Psychiatry

Liliana Alonso Yanez is a board-certified Psychiatric Mental Health Nurse Practitioner with extensive experience in behavioral health services across inpatient, outpatient, and community mental health settings. Her clinical expertise includes psychiatric assessment, diagnosis, medication management, crisis intervention, suicide risk evaluation, and evidence-based treatment planning. She has strong experience working with diverse patient populations and is fluent in both English and Spanish, supporting effective communication and culturally competent care.

In clinical research, Ms. Alonso Yanez serves as a Sub-Investigator supporting industry-sponsored psychiatric clinical trials within the Research Management Partners network. Her research experience includes studies involving major depressive disorder, bipolar disorder, schizophrenia, generalized anxiety disorder, PTSD, ADHD, autism spectrum disorders, and other central nervous system conditions. She also serves as an independent clinical rater trained in standardized psychiatric rating scales such as MADRS, HAM-D, HAM-A, PANSS, YMRS, CGI scales, BPRS, and C-SSRS used in CNS clinical trials.

Ms. Alonso Yanez is trained in Good Clinical Practice (ICH-GCP), FDA-regulated research requirements, Human Subjects Protection, and suicide risk assessment protocols. Her experience supporting protocol-driven psychiatric assessments, ensuring data accuracy, and collaborating with investigators, sponsors, and CROs contributes to reliable study execution and high-quality clinical data across the Research Management Partners clinical research network.

Oneida Garces, MSN, APRN, FNP-C

Sub-Investigator | Psychiatric & CNS Clinical Rater

Oneida Garces is a Board-Certified Family Nurse Practitioner and experienced Sub-Investigator with a strong focus in psychiatry and central nervous system (CNS) clinical research.

She brings extensive clinical experience in psychiatric care, including evaluation, diagnosis, and medication management across a wide range of conditions such as major depressive disorder (MDD), bipolar disorder, schizophrenia, generalized anxiety disorder (GAD), PTSD, ADHD, and other neurodevelopmental disorders.

Ms. Garces is a highly trained and experienced clinical rater, with demonstrated proficiency in administering key psychiatric assessment scales including MADRS, PANSS, HAM-D, HAM-A, CGI-S/I, YMRS, BPRS, and C-SSRS. Her expertise in maintaining inter-rater reliability and supporting both site-based and centralized rating models significantly strengthens data quality in CNS trials.

She is fully trained in ICH-GCP, FDA-regulated research, human subject protection, and holds certifications aligned with ACRP standards. Her research experience includes participation in multiple CNS clinical trials involving schizophrenia and bipolar disorder, contributing to protocol execution, patient monitoring, and data integrity.

With a multidisciplinary background as an international medical graduate, registered nurse, and advanced practice provider, Ms. Garces combines strong clinical judgment with patient-centered care. She plays a critical role in patient engagement, retention, and high-quality study execution, particularly within diverse populations.

Amanda Hernandez, PMHNP-BC

Sub-Investigator | Psychiatric-Mental Health Nurse Practitioner & Clinical Rater

Amanda Hernandez is a Board-Certified Psychiatric-Mental Health Nurse Practitioner (PMHNP-BC) and Sub-Investigator with focused expertise in central nervous system (CNS) disorders and clinical trial execution.

She has extensive training in psychiatric evaluation, diagnosis, medication management, crisis intervention, and suicide risk assessment across inpatient, outpatient, and community-based settings. Her clinical experience includes managing patients with major depressive disorder (MDD), bipolar disorder, schizophrenia, generalized anxiety disorder (GAD), PTSD, ADHD, autism spectrum disorders, and substance use disorders.

Ms. Hernandez is an experienced clinical rater with proficiency in administering standardized psychiatric scales including MADRS, PANSS, HAM-D, HAM-A, CGI-S/I, YMRS, BPRS, and C-SSRS, ensuring high-quality and consistent data collection in CNS clinical trials.

She is trained in ICH-GCP, FDA-regulated research, human subject protection, and ACRP-aligned standards, supporting protocol compliance and audit readiness. Her experience includes participation in multiple CNS clinical trials focused on schizophrenia and bipolar disorder, contributing to subject evaluation, safety monitoring, and study execution.

Bilingual in English and Spanish, Ms. Hernandez plays a key role in patient engagement, recruitment, and retention, particularly within diverse populations. Her background in psychiatric nursing leadership and behavioral health operations further strengthens site-level execution and patient-centered care.